MetadataShow full item record
AbstractGlucose is the main energy substrate for the brain. There is now extensive evidence indicating that the metabolic profile of neural cells with regard to glucose utilization and glycolysis rate is not homogenous, with a marked propensity for glycolytic glucose processing in astrocytes compared to neurons. Methylglyoxal, a highly reactive dicarbonyl compound, is inevitably formed as a by-product of glycolysis. Methylglyoxal is a major cell-permeant precursor of advanced glycation end-products (AGEs), which are associated with several pathologies including diabetes, aging and neurodegenerative diseases. In normal situations, cells are protected against methylglyoxal toxicity by different mechanisms and in particular the glyoxalase system, which represents the most important pathway for the detoxification of methylglyoxal. While the neurotoxic effects of methylglyoxal and AGEs are well characterized, our understanding the glyoxalase system in the brain is more scattered. Considering the high energy requirements (i.e., glucose) of the brain, one should expect that the cerebral glyoxalase system is adequately fitted to handle methylglyoxal toxicity. This review focuses on our actual knowledge on the cellular aspects of the glyoxalase system in brain cells, in particular with regard to its activity in astrocytes and neurons. A main emerging concept is that these two neural cell types have different and energetically adapted glyoxalase defense mechanisms which may serve as protective mechanism against methylglyoxal-induced cellular damage.
CitationAllaman I, Bélanger M and Magistretti PJ (2015) Methylglyoxal, the dark side of glycolysis. Front. Neurosci. 9:23. doi: 10.3389/fnins.2015.00023
SponsorsThis work was supported by grants from Swiss National Science Foundation (FNRS) (no. 310030B-148169/1), from the NCCR Synapsy and from the Biaggi and Panacée Foundations to Pierre J. Magistretti.
PublisherFrontiers Media SA
JournalFrontiers in Neuroscience
PubMed Central IDPMC4321437
The following license files are associated with this item:
- Role of the glyoxalase system in astrocyte-mediated neuroprotection.
- Authors: Bélanger M, Yang J, Petit JM, Laroche T, Magistretti PJ, Allaman I
- Issue date: 2011 Dec 14
- Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.
- Authors: Wetzels S, Wouters K, Schalkwijk CG, Vanmierlo T, Hendriks JJ
- Issue date: 2017 Feb 15
- Glyoxalase II does not support methylglyoxal detoxification but serves as a general trypanothione thioesterase in African trypanosomes.
- Authors: Wendler A, Irsch T, Rabbani N, Thornalley PJ, Krauth-Siegel RL
- Issue date: 2009 Jan
- Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells.
- Authors: Hansen F, de Souza DF, Silveira Sda L, Hoefel AL, Fontoura JB, Tramontina AC, Bobermin LD, Leite MC, Perry ML, Gonçalves CA
- Issue date: 2012 Dec
- Yeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins.
- Authors: Gomes RA, Vicente Miranda H, Silva MS, Graça G, Coelho AV, Ferreira AE, Cordeiro C, Freire AP
- Issue date: 2006 Dec